Two healthy outcomes matter
Recipient benefit never cancels the obligation to minimize donor risk, preserve voluntary consent, and provide lifelong donor follow-up.
Liver transplant cost in Turkey
A living-donor liver transplant quote should treat recipient and donor independently, name the graft and imaging plan, document lawful relationship and ethics review, include two surgical and anesthesia teams, state blood-product and ICU assumptions, and explain how rejection, infection, vascular or biliary complications, re-operation, readmission, and lifelong immunosuppression are billed.
How much does liver transplant cost in Turkey?
For international patients with an accepted living donor, liver transplant in Turkey is commonly budgeted at TRY 2,350,000 to 4,230,000 (about USD 50,000 to 90,000). Acute instability, complex vascular anatomy, prior abdominal surgery, high blood-product use, prolonged ICU care, biliary or vascular intervention, rejection, infection, or donor complications can increase the total beyond TRY 5,170,000 (about USD 110,000).
USD illustrations use about TRY 47 per USD near the official 17 July 2026 indicative rate. Clarify whether TRY, EUR, or USD governs the transplant package, imported medicines, blood products, additions, and refunds.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: TRY and USD
Recipient benefit never cancels the obligation to minimize donor risk, preserve voluntary consent, and provide lifelong donor follow-up.
CT volumetry and arterial, portal, hepatic venous, and biliary anatomy determine donor side, graft size, and reconstruction.
International recipient-donor pairs need current center guidance on relationship evidence, ethics review, restrictions, and certified documents before travel.
Blood use, ventilation, kidney support, infection, graft function, re-operation, and interventional radiology can dominate the final bill.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | TRY | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Stable accepted living-donor pathway | TRY 2,350,000 - 3,290,000 | USD 50,000 - 70,000 | Clinically stable recipient, suitable related donor, favorable graft volume and vessels, no uncontrolled infection, and expected routine ICU course. | Should include two workups, ethics process, donor hepatectomy, recipient transplant, specified ICU and ward days, and early reviews. |
| High-complexity recipient or graft | TRY 3,290,000 - 4,230,000 | USD 70,000 - 90,000 | Portal thrombosis, prior surgery, obesity, renal dysfunction, small-for-size concern, malignancy assessment, or complex reconstruction. | Needs explicit graft planning, blood, interventional radiology, dialysis, and critical-care assumptions. |
| Prolonged ICU or complication course | TRY 4,230,000 - 5,170,000+ | USD 90,000 - 110,000+ | Sepsis, major bleeding, vascular or biliary complication, graft dysfunction, re-operation, rejection, or donor adverse event. | Must be estimated as variable high-acuity care rather than guaranteed package coverage. |
Usually included
Liver diagnosis, severity, cancer staging, cardiac, lung, kidney, infection, vascular, nutrition, and psychosocial assessment.
Define repeated and special tests.
General health, liver quality and volume, anatomy, psychosocial, consent, and legal assessment.
The donor may withdraw confidentially.
Donor hepatectomy and recipient explant and implantation with separate teams, anesthesia, theatre, and standard consumables.
Clarify blood and reconstruction allowances.
Stated ICU and ward days, routine imaging, labs, drug levels, and early donor and recipient reviews.
Get overstay rates for both.
Confirm separately
Certified translation, apostille, relationship verification, ethics interviews, and delayed scheduling.
Do not buy flights before acceptance.
Blood products, dialysis, ECMO, prolonged ventilation, special antimicrobials, or extended ICU when capped.
Ask for unit prices.
Angiography, stent, drain, ERCP, re-operation, biopsy, or graft rescue.
These can occur after discharge.
Immunosuppression, infection prevention, cancer surveillance, donor follow-up, accommodation, and home specialists.
Model a long horizon.
Candidate context
Liver transplant candidacy integrates liver-failure severity, decompensation, tumor criteria, infection, heart and lung reserve, kidney function, nutrition, frailty, adherence, psychosocial support, and whether another treatment remains appropriate. Living donation additionally requires a healthy voluntary donor with adequate remnant and graft volumes and suitable anatomy. Confusion, bleeding, sepsis, severe swelling, kidney failure, or rapidly worsening jaundice needs urgent local treatment.
MELD-related severity, decompensation, acute failure, cancer status, infection, and expected post-transplant benefit guide timing.
Age, liver fat, volume, vessels, bile ducts, medical risk, psychosocial context, and independent consent are assessed.
Graft-to-recipient size, venous outflow, portal inflow, arterial supply, and biliary anatomy shape technical feasibility.
Reliable medicine supply, frequent labs, imaging, infection access, and a home transplant or liver team are mandatory.
Antiviral, abstinence and addiction care, metabolic, autoimmune, or other disease-specific treatment may stabilize selected patients.
Ablation, embolization, resection, radiation, or systemic therapy may bridge or replace transplant in selected tumors.
When transplant cannot offer sufficient benefit or is unsafe, symptom, complication, and goals-of-care support remains important.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
Often considered for adult recipients when volume and donor anatomy are acceptable.
Donor remnant safety comes first.
May suit smaller recipients or pediatric pathways depending on volume.
Center age-group experience matters.
Portal thrombosis or unusual arterial and venous anatomy can require grafts and advanced technique.
Price blood and intervention readiness.
National allocation and foreign eligibility differ from a planned living-donor package.
Never assume list access; obtain current official advice.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Istanbul | TRY 2,585,000 - 4,700,000 | USD 55,000 - 100,000 | Broad high-complexity transplant choice. | High two-person living cost. |
| Ankara | TRY 2,491,000 - 4,465,000 | USD 53,000 - 95,000 | Strong academic and tertiary programs. | Confirm foreign-donor pathway. |
| Izmir | TRY 2,350,000 - 4,230,000 | USD 50,000 - 90,000 | Selected established liver programs. | Verify adult and pediatric scope. |
| Antalya | TRY 2,491,000 - 4,465,000 | USD 53,000 - 95,000 | Selected private international pathways. | Confirm organ license. |
| Bursa | TRY 2,256,000 - 3,995,000 | USD 48,000 - 85,000 | Potential value only at qualified centers. | Verify interventional backup. |
| Kocaeli and Gebze | TRY 2,350,000 - 4,230,000 | USD 50,000 - 90,000 | Marmara tertiary options. | Budget donor and caregiver transport. |
| Adana | TRY 2,256,000 - 3,995,000 | USD 48,000 - 85,000 | Selected regional transplant capability. | Check current international activity. |
| Malatya | TRY 2,256,000 - 3,995,000 | USD 48,000 - 85,000 | Known regional transplant expertise requires current program verification. | Assess travel and long-stay logistics. |
| Konya | TRY 2,115,000 - 3,760,000 | USD 45,000 - 80,000 | Case-specific availability. | Do not compare price without volume and ICU evidence. |
| Gaziantep | TRY 2,115,000 - 3,760,000 | USD 45,000 - 80,000 | Program-level validation is essential. | Require written donor acceptance. |
Estimate variables
Acute failure, kidney dysfunction, infection, portal thrombosis, and intensive-care status raise exposure.
A stable package may not apply.
Volume, fat, vessels, bile ducts, and reconstruction needs determine operative complexity.
CT-led quote required.
Bleeding, ventilation, dialysis, vasopressors, and re-operation can dominate cost.
Get unit and daily rates.
Rejection, infection, biliary leak or stricture, thrombosis, and graft dysfunction require intervention.
Maintain contingency.
Medical cost breakdown
Liver severity, cancer, heart, lung, kidney, infection, vascular, nutrition, and psychosocial workup.
Use current imaging.
Liver tests, CT volumetry, vessels, bile ducts, fat, medical and psychosocial safety.
Independent process.
Identity, relationship, translations, interviews, and formal approval.
Confirm before travel.
Separate surgical team, anesthesia, theatre, ward, pain, and monitoring.
Define donor complications.
Explant, graft implantation, reconstruction, ICU, ward, imaging, labs, and medicines.
State blood and day caps.
Dialysis, ERCP, radiology, re-operation, rejection, infection, or prolonged ICU.
Variable additions.
Liver tests, drug levels, Doppler, infection, rejection, and biliary review.
Frequent early access.
Liver regeneration, wound, pain, nutrition, function, mental health, and long-term monitoring.
Provide independent follow-up.
Immunosuppression, prophylaxis, metabolic care, vaccines, and cancer surveillance.
Secure home supply.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Flexible flights and assistance for multiple travelers.
Schedules can change.
Nearby stay suitable for two recoveries and frequent tests.
Plan hygiene and nutrition.
Blood, ICU, intervention, readmission, extra medicines, and delayed flights.
Do not rely on the base package.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Obtain current written requirements from the authorized transplant center for the foreign recipient-donor pair.
Turkish authorities can require additional ethics review or limit access where organ-trafficking risk is suspected.
Payment, donor sourcing, coercion, or false relationship evidence is unacceptable and should stop the process.
Verify current liver-transplant activity permission and international-health-tourism authorization.
Check official visa and stay requirements for recipient, donor, and caregiver before payment.
Hospital selection
Adult or pediatric scope, living-donor activity, complex vascular and biliary expertise, and current licensing.
Match the exact case.
Independent advocate, volumetry, confidential withdrawal, ICU access, complication response, and long-term review.
Ask for donor outcomes.
Transplant ICU, blood bank, dialysis, infection, hepatology, pathology, ERCP, interventional radiology, and re-operation.
Round-the-clock capability.
Recipient, graft, donor, vascular, biliary, infection, and readmission outcomes by timeframe.
Demand definitions.
Treating team
Separate donor and recipient leadership plans graft choice, retrieval, implantation, and complications.
Confirms indication, severity, infection, cancer, medicines, rejection, and continuity.
Manages bleeding, hemodynamics, ventilation, kidney support, and early graft function.
Provides graft planning and rapid diagnosis and treatment of vascular, biliary, rejection, and infectious problems.
Treatment timeline
Assess recipient need, donor health, relationship, imaging, urgency, and provisional budget.
Complete separate workups, graft volumetry, anatomy, ethics, and informed consent.
Proceed only after donor safety, recipient readiness, legal approval, graft plan, and backup are confirmed.
Donor retrieval and recipient transplantation are performed with separate safety responsibilities.
Monitor graft, blood, kidney, breathing, infection, vascular and biliary flow, wounds, and medicines.
Both home teams receive operation, anatomy, pathology, medicines, labs, imaging, warning signs, and follow-up.
Risks and edge cases
No transplant should proceed and no pressure is acceptable.
Review refund terms.
Massive transfusion, dialysis, prolonged ICU, re-operation, or graft rescue may be needed.
High cost exposure.
Arterial, portal, or venous problems need urgent imaging and intervention.
Verify 24-hour response.
Drainage, ERCP, radiology, or surgery may be required after discharge.
Plan local access.
Biopsy, adjusted immunosuppression, antimicrobials, and readmission may be needed.
Never interrupt medicines.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Living-donor rules | Indian donor authorization and relationship rules govern foreign pairs. | Turkish relationship, ethics, foreign-case, and donor-protection provisions apply. | Strict donor and transplant rules require current center confirmation. | Get written legal acceptance before travel. |
| Program depth | Several high-volume living-donor liver programs. | Established advanced programs with convenient routes for Europe and nearby regions. | Selected leading transplant centers with narrower international choice. | Compare donor safety and rescue depth. |
| Journey cost | Potentially lower hospital and long-stay costs. | Higher major-city living and imported medicine exposure. | Private hospital and long-stay costs can be substantial. | Model two patients plus caregiver and complications. |
Decision guidance
An authorized program accepts both files, documents donor safeguards and ethics pathway, and provides a two-operation, ICU, blood, intervention, and follow-up estimate.
Anyone sells or finds a donor, guarantees committee approval, requests false documents, or minimizes donor risk.
Confusion, vomiting blood, severe infection, low blood pressure, breathing difficulty, kidney failure, or rapidly worsening jaundice occurs.
Reports for review
Prepare distinct recipient and donor records with certified identity and relationship evidence. Include complete liver diagnosis, severity and cancer workup, current CT or MRI source files, portal and vascular status, admissions and infections, donor CT volumetry and health assessment, medicines, and home transplant contacts.
Upload medical reportsProvide the complete liver diagnosis, meld-related labs and decompensation history as a readable record for clinical and cost review.
Provide the complete ct or mri source images and cancer markers as a readable record for clinical and cost review.
Provide the complete cardiac, lung, kidney and infection assessment as a readable record for clinical and cost review.
Provide the complete medicines, transfusions, operations and allergies as a readable record for clinical and cost review.
Submit clear donor and recipient identity records plus every document used to establish their relationship for legal and financial review.
Provide the complete medical, liver and psychosocial assessment as a readable record for clinical and cost review.
Provide the complete ct volumetry and vascular anatomy as a readable record for clinical and cost review.
Provide the complete independent consent and family context as a readable record for clinical and cost review.
Provide the complete home hepatologist and emergency facility as a readable record for clinical and cost review.
Provide the complete passport, visa, translation and apostille plan as a readable record for clinical and cost review.
Document which immunosuppressants and monitoring medicines are obtainable at home, their insurance status, and fallback supply plan.
Provide the complete caregiver, housing and contingency plan as a readable record for clinical and cost review.
Common questions
No legitimate pathway should sell or source a living donor. The pair must meet current lawful and ethical requirements.
Non-standard relationships may require intensive ethics review and may not be accepted. Obtain written guidance before travel.
It should be separately described with workup, operation, room, follow-up, and complication terms.
It estimates donor remnant and recipient graft size and maps vessels and related anatomy for safety.
Do not assume national-list access. Ask an authorized center and competent authority for current written eligibility.
Package policies vary. High-risk recipients should obtain unit prices and a realistic blood-product assumption.
Their timelines differ and depend on healing, graft function, medicines, complications, and travel clearance.
Most recipients need long-term immunosuppression with laboratory monitoring and individualized adjustment.
Imaging, drainage, endoscopy, radiology, or surgery may be needed and can add substantial cost.
Carry both operation notes, graft anatomy, pathology, imaging, labs, medicines, donor and recipient plans, and urgent contacts.
Review and sources
The estimate models two independent evaluations, lawful donor review, graft planning, two operations, blood and ICU exposure, early recipient and donor care, and high-impact complications. Turkish transplant law and ethical principles are eligibility gates. The currency illustration is anchored near 17 July 2026; only an authorized program’s accepted two-patient plan can establish cost.
This guide cannot establish liver-transplant eligibility, donor legality or safety, ethics approval, graft suitability, prognosis, or travel fitness. Never buy an organ or falsify documents. Confusion, bleeding, fever, breathing difficulty, low blood pressure, kidney failure, or rapidly worsening jaundice requires urgent local care.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Living donation, ethics review, donor protection, licensing, and outcomes monitoring.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Current regulatory amendment.
Declaration of Istanbul Custodian Group · Accessed 2026-07-19
Supports: Ethical transplantation and anti-commercialism.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: International service rules.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Provider verification.
Central Bank of the Republic of Turkey via e-Government Gateway · Accessed 2026-07-19
Supports: Conversion context.
Related planning
Compare donor and ethics planning.
Review cellular transplant care.
Plan cardiac optimization.
Compare another destination.
Understand recipient and donor stages.
Compare program depth.
Review team selection.
Assess wider backup.
Prepare two files.
Request staged pricing.
Questions about an estimate? Email support@virellohealth.com.